Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
Email Facebook Twitter Google+ LinkedIn Comments

BioGenes GmbH

Apr 2009
BioGenes GmbH of Berlin, a developer of antibodies, has been chosen as a partner of cNEUPRO, a research project funded by the European Union. The project focuses on analyzing neurodegenerative diseases and discovering novel biomarkers, in hopes of providing early and differential diagnosis of Alzheimer’s disease. The company will provide laboratory facilities and personnel to develop monoclonal antibodies against specific dementia biomarkers in blood and cerebrospinal fluid.

antibodiesBioGenes GmbHBiophotonicsneurodegenerative diseasesNews & Features

Terms & Conditions Privacy Policy About Us Contact Us
back to top
Facebook Twitter Instagram LinkedIn YouTube RSS
©2018 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA,

Photonics Media, Laurin Publishing
x Subscribe to BioPhotonics magazine - FREE!
We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.